{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T00:36:39Z","timestamp":1791592599149,"version":"4.3.4"},"reference-count":35,"publisher":"SAGE Publications","issue":"4","license":[{"start":{"date-parts":[[2021,9,18]],"date-time":"2021-09-18T00:00:00Z","timestamp":1631923200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"funder":[{"name":"Vygon"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["J Vasc Access"],"published-print":{"date-parts":[[2023,7]]},"abstract":"<jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>\n                      Occupational exposure to cytotoxic drugs can lead to significant health problems. This study was designed to evaluate the risk of 5-fluorouracil (5-FU) contamination for nurses when disconnecting the infusion line of an elastomeric pump from a non-coring needle, by comparing three configurations: the first one using standard Male and Female Luer lock (Group 1), the second one using a needle-free connector (NFC) and a Male Luer lock (Group 2) and the third one using a closed-system transfer device (CSTD), Qimono\n                      <jats:sup>\u00ae<\/jats:sup>\n                      (Group 3).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>In this in vitro study, 10 elastomeric pumps for each of the three groups were filled with 5-FU and a tissue mimicking the patient\u2019s arm was placed below the connection between the infusion line and the tubing of non-coring needle. After 48 h of infusion, disconnection was performed by a nurse with a wipe soaked in a mix of chlorhexidine and isopropyl alcohol in order to mimic care practices. For each pump, the tissue, the pair of gloves and the wipes used during the disconnection were collected for analysis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>Median level of overall 5-FU contamination (gloves + wipes + tissues) in group 3 was significantly lower than in group 1 ( p = 0.018) and group 2 ( p = 0.036). There was no difference between groups 1 and 2. Results per sample type showed no difference in contamination between the three configurations for the gloves as well as for the tissues. Concerning the wipes, the lowest contamination was observed in group 3, representing a mean reduction of 61% compared to group 1 and a mean reduction of 43% compared to group 2.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>\n                      The use of Qimono\n                      <jats:sup>\u00ae<\/jats:sup>\n                      appears to significantly reduce 5-FU contamination when disconnecting infusion lines of an elastomeric pump unlike NFC and standard Luer lock.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1177\/11297298211044017","type":"journal-article","created":{"date-parts":[[2021,9,18]],"date-time":"2021-09-18T07:40:30Z","timestamp":1631950830000},"page":"653-659","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":3,"title":["Safe disconnection of 5-fluorouracil elastomeric pumps: The benefit of a closed-system-transfer device designed for cytotoxic drug administration\/perfusion"],"prefix":"10.1177","volume":"24","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3396-7918","authenticated-orcid":false,"given":"Pesqu\u00e9","family":"Rapha\u00eblle","sequence":"first","affiliation":[{"name":"Pharmacy, Saint-Louis Hospital (AP-HP), Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peyrilles","family":"Elodie","sequence":"additional","affiliation":[{"name":"Pharmacy, Saint-Louis Hospital (AP-HP), Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jourdan","family":"Nathalie","sequence":"additional","affiliation":[{"name":"Pharmacy, Saint-Louis Hospital (AP-HP), Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Albert","family":"Odile","sequence":"additional","affiliation":[{"name":"Catheter Day Care Unit, Saint-Louis Hospital (AP-HP), Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sessink","family":"Paul","sequence":"additional","affiliation":[{"name":"Exposure Control, Bohus-Bj\u00f6rk\u00f6, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Madelaine","family":"Isabelle","sequence":"additional","affiliation":[{"name":"Pharmacy, Saint-Louis Hospital (AP-HP), Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Levert","family":"H\u00e9l\u00e8ne","sequence":"additional","affiliation":[{"name":"Pharmacy, Saint-Louis Hospital (AP-HP), Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2021,9,18]]},"reference":[{"key":"bibr1-11297298211044017","doi-asserted-by":"publisher","DOI":"10.2165\/00002018-199920040-00004"},{"key":"bibr2-11297298211044017","first-page":"102","volume":"4","author":"Momeni M","year":"2013","journal-title":"Int J Occup Environ Med"},{"key":"bibr3-11297298211044017","doi-asserted-by":"publisher","DOI":"10.1002\/ajim.22553"},{"key":"bibr4-11297298211044017","doi-asserted-by":"publisher","DOI":"10.1097\/00043764-199908000-00004"},{"key":"bibr5-11297298211044017","unstructured":"Ndaw S, Denis F, Marsan P, et al. Exposition professionnelle des personnels de sant\u00e9 hospitaliers aux m\u00e9dicaments cytotoxiques. Biom\u00e9trologie et mesure de la contamination des surfaces \u2013 article de revue \u2013 INRS, http:\/\/www.inrs.fr\/media.html?refINRS=TF%20255 (2018, accessed 1 July 2019)."},{"key":"bibr6-11297298211044017","doi-asserted-by":"publisher","DOI":"10.1188\/15.ONF.42-06AP"},{"key":"bibr7-11297298211044017","first-page":"252","volume":"12","author":"Ndaw S","year":"2018","journal-title":"Bull Epidemiol Hebd"},{"key":"bibr8-11297298211044017","first-page":"231","volume":"51","author":"Fransman W","year":"2007","journal-title":"Ann Occup Hyg"},{"key":"bibr9-11297298211044017","doi-asserted-by":"publisher","DOI":"10.1007\/s10661-014-3969-1"},{"key":"bibr10-11297298211044017","doi-asserted-by":"publisher","DOI":"10.1016\/j.toxlet.2011.03.028"},{"key":"bibr11-11297298211044017","doi-asserted-by":"publisher","DOI":"10.1007\/s00420-012-0742-z"},{"key":"bibr12-11297298211044017","doi-asserted-by":"publisher","DOI":"10.1097\/01.NAJ.0000552583.69729.51"},{"key":"bibr13-11297298211044017","doi-asserted-by":"publisher","DOI":"10.1016\/j.toxlet.2010.04.026"},{"key":"bibr14-11297298211044017","volume-title":"Preventing occupational exposure to cytotoxic and other hazardous drugs","author":"European Parliament","year":"2016"},{"key":"bibr15-11297298211044017","unstructured":"CDC. NIOSH list of antineoplastic and other hazardous drugs in healthcare settings, https:\/\/www.cdc.gov\/niosh\/docs\/2016-161\/pdfs\/2016-161.pdf (2016, accessed 2 July 2019)."},{"key":"bibr16-11297298211044017","unstructured":"US Occupational Health and Safety Administration. Controlling occupational exposure to hazardous drugs, https:\/\/www.osha.gov\/SLTC\/hazardousdrugs\/controlling_occex_hazardousdrugs.html (2016, accessed 5 July 2019)."},{"key":"bibr17-11297298211044017","doi-asserted-by":"publisher","DOI":"10.3747\/co.21.2151"},{"key":"bibr18-11297298211044017","unstructured":"CDC. NIOSH alert: preventing occupational exposure to antineoplastic and other hazardous drugs in health care settings, www.cdc.gov\/niosh\/docs\/2004-165 (2004, accessed 2 July 2019)."},{"key":"bibr19-11297298211044017","doi-asserted-by":"crossref","DOI":"10.37573\/9781585285747","volume-title":"The chapter <800> answer book","author":"Kienle PC","year":"2017"},{"key":"bibr20-11297298211044017","unstructured":"European Parliament. Directive (EU) 2019\/130 of the European Parliament and of the Council of 16 January 2019 amending directive 2004\/37\/EC on the protection of workers from the risks related to exposure to carcinogens or mutagens at work (text with EEA relevance.), http:\/\/data.europa.eu\/eli\/dir\/2019\/130\/oj\/eng (2019, accessed 19 August 2019)."},{"key":"bibr21-11297298211044017","doi-asserted-by":"publisher","DOI":"10.1177\/1078155211416531"},{"key":"bibr22-11297298211044017","doi-asserted-by":"publisher","DOI":"10.1093\/ajhp\/60.22.2314"},{"key":"bibr23-11297298211044017","doi-asserted-by":"publisher","DOI":"10.1177\/1078155212468367"},{"key":"bibr24-11297298211044017","doi-asserted-by":"publisher","DOI":"10.2146\/ajhp160948"},{"key":"bibr25-11297298211044017","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0159052"},{"key":"bibr26-11297298211044017","first-page":"153","volume":"53","author":"Yoshida J","year":"2009","journal-title":"Ann Occup Hyg"},{"key":"bibr27-11297298211044017","first-page":"36","volume":"40","author":"G\u00f3mez-\u00c1lvarez S","year":"2016","journal-title":"Farm Hosp"},{"key":"bibr28-11297298211044017","doi-asserted-by":"publisher","DOI":"10.1177\/1078155210361431"},{"key":"bibr29-11297298211044017","doi-asserted-by":"publisher","DOI":"10.1310\/hpj4203-219"},{"key":"bibr30-11297298211044017","doi-asserted-by":"publisher","DOI":"10.1016\/j.mrgentox.2005.07.008"},{"key":"bibr31-11297298211044017","doi-asserted-by":"publisher","DOI":"10.1002\/jat.1735"},{"key":"bibr32-11297298211044017","doi-asserted-by":"publisher","DOI":"10.1016\/j.jval.2019.09.1646"},{"key":"bibr33-11297298211044017","volume-title":"GUIDE DE RECOMMANDATIONS DE DISPOSITIFS M\u00c9DICAUX Pr\u00e9paration Administration des M\u00e9dicaments \u00e0 Risques pour le Personnel et l\u2019Environnement","author":"Crauste-Manciet S","year":"2007"},{"key":"bibr34-11297298211044017","unstructured":"UNE. PNE 111001 Sistemas cerrados de transferencia para la manipulaci\u00f3n de medicamentos peligrosos. Requisitos generales y m\u00e9todos de ensayo, https:\/\/www.une.org\/encuentra-tu-norma\/busca-tu-norma\/proyecto?c=P0051678 (2014, accessed 27 November 2019)."},{"key":"bibr35-11297298211044017","volume-title":"ESMO Congress","author":"De Munter J"}],"container-title":["The Journal of Vascular Access"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/11297298211044017","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/11297298211044017","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/11297298211044017","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,2]],"date-time":"2026-05-02T03:19:17Z","timestamp":1777691957000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/11297298211044017"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9,18]]},"references-count":35,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2023,7]]}},"alternative-id":["10.1177\/11297298211044017"],"URL":"https:\/\/doi.org\/10.1177\/11297298211044017","relation":{},"ISSN":["1129-7298","1724-6032"],"issn-type":[{"value":"1129-7298","type":"print"},{"value":"1724-6032","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,9,18]]}}}